# Novo Nordisk sues rival over false advertising

Novo Nordisk, the maker of diabetes drug Ozempic, has filed a lawsuit against a rival company for allegedly making false claims about a competing product. The lawsuit targets advertising that may mislead consumers and healthcare providers. This case highlights ongoing legal battles in the lucrative weight-loss and diabetes drug market.

**Importance:** 3/5

## Sources

### Business
- [BBC Business](https://www.bbc.co.uk/news/articles/c3v0rzd2l17o?at_medium=RSS&at_campaign=rss) — Tue, 21 Jul 2026 13:47:23 GMT
- [The Guardian Biz](https://www.theguardian.com/business/2026/jul/21/novo-nordisk-eli-lilly-weight-loss-ads) — Tue, 21 Jul 2026 17:21:19 GMT
- [Fox News Business](https://www.foxbusiness.com/retail/novo-nordisk-sues-eli-lilly-claims-weight-loss-drug-ads) — Tue, 21 Jul 2026 21:23:20 GMT